CLINICAL_TRIALS
trial_result
· 2018-01-18
Clinical Trial Update: Safety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid Arthritis [Phase 3]
Summary
Phase 3 trial of BI 695500 in adults with moderately to severely active rheumatoid arthritis terminated; results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: TERMINATED | Results posted: 2018-01-18